Home
Granules India Ltd Board of Directors
Board of Directors at Granules India Ltd
Non-Exec. & Independent Dir.
Chairman & Managing Director
Company Sec. & Compli. Officer
Executive Director
Non-Exec & Non-Independent Dir
Key Highlights
- C Krishna Prasad joins the board as CMD & Executive Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- KANDIRAJU VENKATA SITARAMRAO joins the board as Non Independent Executive Director / Joint MD, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Uma Devi Chigurupati joins the board as ED (Non-Independent), in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Harsha Chigurupati joins the board as ED (Non-Independent), in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- PRIYANKA CHIGURUPATI joins the board as NIED /Head /Promoter, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Granules India Ltd
NSE: GRANULES
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 31 Oct 2025 | 565.3 |
| 30 Oct 2025 | 574.55 |
| 29 Oct 2025 | 571.25 |
| 28 Oct 2025 | 569.55 |
| 27 Oct 2025 | 565.95 |
| 24 Oct 2025 | 561.3 |
| 23 Oct 2025 | 559.35 |
| 21 Oct 2025 | 570 |
| 20 Oct 2025 | 565.4 |
| 17 Oct 2025 | 568.15 |
Company Fundamentals for Granules India Ltd
Market Cap
13,718 Cr
EPS
19.7
P/E Ratio (TTM)
28.7
P/B Ratio (TTM)
3.7
Day’s High
575.3
Day’s Low
564.05
DTE
0.4
ROE
13.5
52 Week High
627.45
52 Week Low
412.05
ROCE
14.8
Market Price of Granules India Ltd
1M
1Y
3Y
5Y
Granules India Ltd News Hub
Granules India Ltd soars 1.63%, up for third straight session
Granules India Ltd rose for a third straight session today. The stock is quoting at Rs 686.45, up 1.
Read more
21 Aug 24
Granules Pharmaceuticals receives USFDA approval for Glycopyrrolate Oral Solution
Granules India announced today that the U.S. Food and Drug Administration (FDA) has approved its Abb
Read more
20 Aug 24
Granules India rises on USFDA nod for oral drug Glycopyrrolate
The ANDA has been filed by Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary o
Read more
20 Aug 24
Granules India receives US FDA nod for depression treatment drug Trazodone
It is bioequivalent and therapeutically equivalent to the reference listed drug Desyrel Tablets of P
Read more
09 Aug 24
